NIH-funded research NIH-funded research

Genomic mapping of nonfalciparum malaria to guide control in Africa

Official title: Emergents International Centers of Excellence for Malaria Research

Funded at University of Florida · NIH-11507593 · Data updated 2026-11-12

A large, multi-institution project aims to map the spread and transmission of nonfalciparum malaria (Po, Pv, Pm) to better understand where these infections come from and how mosquitoes pass them on.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startApril 22, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$36,054
NIH project number3U19AI181594-03S2
Project IDNIH-11507593 on NIH RePORTER

Who could benefit from this research

Could help

Individuals in malaria-endemic regions, particularly in Africa, who may be harboring nonfalciparum infections and could benefit from improved diagnosis and vector-control strategies.

Less likely to help

Individuals without malaria exposure or those in settings without access to targeted diagnostic tools and vector-control interventions may see limited direct benefit.

What this research studies

This program project will use genomic epidemiology to identify where nonfalciparum malaria infections live, how easily they move to mosquitoes, and how insecticide resistance in vectors affects transmission. It focuses on Po, Pv, and Pm, which are harder to diagnose with standard field tests, and will apply sensitive detection methods to reveal the true disease burden. Researchers will study mosquito behavior and the impact of insecticides on transmission to develop better prevention strategies. The effort involves collaboration across multiple sites, with data guiding targeted interventions in affected regions.

Why it matters

Potential benefit: Better understanding of nonfalciparum malaria could lead to more accurate diagnosis, tailored control measures, and reduced transmission in areas with high disease burden.

How similar studies have gone: Previous work has improved understanding of Plasmodium falciparum and vivax; this project extends genomic approaches to rarer nonfalciparum infections, which is promising but underexplored.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Dinglasan, Rhoel David Ramos — University of Florida
  • Study coordinator: Dinglasan, Rhoel David Ramos

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.